Neural precursor cells induce cell death of high-grade astrocytomas via stimulation of TRPV1

Primary astrocytomas of World Health Organization grade 3 and grade 4 (HG-astrocytomas) are preponderant among adults and are almost invariably fatal despite multimodal therapy. Here, we show that the juvenile brain has an endogenous defense mechanism against HG-astrocytomas. Neural precursor cells...

Full description

Bibliographic Details
Main Authors: Stock, Kristin, Kumar, Jitender, Synowitz, Michael, Petrosino, Stefania, Imperatore, Roberta, Smith, Ewan St. J., Wend, Peter, Purfürst, Bettina, Nuber, Ulrike A., Gurok, Ulf, Matyash, Vitali, Wälzlein, Joo-Hee, Chirasani, Sridhar R., Dittmar, Gunnar, Cravatt, Benjamin F., Momma, Stefan, Lewin, Gary R., Ligresti, Alessia, De Petrocellis, Luciano, Cristino, Luigia, Di Marzo, Vincenzo, Kettenmann, Helmut, Glass, Rainer
Format: Online
Language:English
Published: 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480991/
id pubmed-3480991
recordtype oai_dc
spelling pubmed-34809912013-07-26 Neural precursor cells induce cell death of high-grade astrocytomas via stimulation of TRPV1 Stock, Kristin Kumar, Jitender Synowitz, Michael Petrosino, Stefania Imperatore, Roberta Smith, Ewan St. J. Wend, Peter Purfürst, Bettina Nuber, Ulrike A. Gurok, Ulf Matyash, Vitali Wälzlein, Joo-Hee Chirasani, Sridhar R. Dittmar, Gunnar Cravatt, Benjamin F. Momma, Stefan Lewin, Gary R. Ligresti, Alessia De Petrocellis, Luciano Cristino, Luigia Di Marzo, Vincenzo Kettenmann, Helmut Glass, Rainer Article Primary astrocytomas of World Health Organization grade 3 and grade 4 (HG-astrocytomas) are preponderant among adults and are almost invariably fatal despite multimodal therapy. Here, we show that the juvenile brain has an endogenous defense mechanism against HG-astrocytomas. Neural precursor cells (NPCs) migrate to HG-astrocytomas, reduce glioma expansion and prolong survival by releasing a group of fatty acid ethanolamides that have agonistic activity on the vanilloid receptor (transient receptor potential vanilloid subfamily member-1; TRPV1). TRPV1 expression is higher in HG-astrocytomas than in tumor-free brain and TRPV1 stimulation triggers tumor cell death via the activating transcription factor-3 (ATF3) controlled branch of the ER stress pathway. The anti-tumorigenic response of NPCs is lost with aging. NPC-mediated tumor suppression can be mimicked in the adult brain by systemic administration of the synthetic vanilloid Arvanil, suggesting that TRPV1 agonists hold potential as new HG-astrocytoma therapeutics. 2012-07-22 2012-08 /pmc/articles/PMC3480991/ /pubmed/22820645 http://dx.doi.org/10.1038/nm.2827 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Stock, Kristin
Kumar, Jitender
Synowitz, Michael
Petrosino, Stefania
Imperatore, Roberta
Smith, Ewan St. J.
Wend, Peter
Purfürst, Bettina
Nuber, Ulrike A.
Gurok, Ulf
Matyash, Vitali
Wälzlein, Joo-Hee
Chirasani, Sridhar R.
Dittmar, Gunnar
Cravatt, Benjamin F.
Momma, Stefan
Lewin, Gary R.
Ligresti, Alessia
De Petrocellis, Luciano
Cristino, Luigia
Di Marzo, Vincenzo
Kettenmann, Helmut
Glass, Rainer
spellingShingle Stock, Kristin
Kumar, Jitender
Synowitz, Michael
Petrosino, Stefania
Imperatore, Roberta
Smith, Ewan St. J.
Wend, Peter
Purfürst, Bettina
Nuber, Ulrike A.
Gurok, Ulf
Matyash, Vitali
Wälzlein, Joo-Hee
Chirasani, Sridhar R.
Dittmar, Gunnar
Cravatt, Benjamin F.
Momma, Stefan
Lewin, Gary R.
Ligresti, Alessia
De Petrocellis, Luciano
Cristino, Luigia
Di Marzo, Vincenzo
Kettenmann, Helmut
Glass, Rainer
Neural precursor cells induce cell death of high-grade astrocytomas via stimulation of TRPV1
author_facet Stock, Kristin
Kumar, Jitender
Synowitz, Michael
Petrosino, Stefania
Imperatore, Roberta
Smith, Ewan St. J.
Wend, Peter
Purfürst, Bettina
Nuber, Ulrike A.
Gurok, Ulf
Matyash, Vitali
Wälzlein, Joo-Hee
Chirasani, Sridhar R.
Dittmar, Gunnar
Cravatt, Benjamin F.
Momma, Stefan
Lewin, Gary R.
Ligresti, Alessia
De Petrocellis, Luciano
Cristino, Luigia
Di Marzo, Vincenzo
Kettenmann, Helmut
Glass, Rainer
author_sort Stock, Kristin
title Neural precursor cells induce cell death of high-grade astrocytomas via stimulation of TRPV1
title_short Neural precursor cells induce cell death of high-grade astrocytomas via stimulation of TRPV1
title_full Neural precursor cells induce cell death of high-grade astrocytomas via stimulation of TRPV1
title_fullStr Neural precursor cells induce cell death of high-grade astrocytomas via stimulation of TRPV1
title_full_unstemmed Neural precursor cells induce cell death of high-grade astrocytomas via stimulation of TRPV1
title_sort neural precursor cells induce cell death of high-grade astrocytomas via stimulation of trpv1
description Primary astrocytomas of World Health Organization grade 3 and grade 4 (HG-astrocytomas) are preponderant among adults and are almost invariably fatal despite multimodal therapy. Here, we show that the juvenile brain has an endogenous defense mechanism against HG-astrocytomas. Neural precursor cells (NPCs) migrate to HG-astrocytomas, reduce glioma expansion and prolong survival by releasing a group of fatty acid ethanolamides that have agonistic activity on the vanilloid receptor (transient receptor potential vanilloid subfamily member-1; TRPV1). TRPV1 expression is higher in HG-astrocytomas than in tumor-free brain and TRPV1 stimulation triggers tumor cell death via the activating transcription factor-3 (ATF3) controlled branch of the ER stress pathway. The anti-tumorigenic response of NPCs is lost with aging. NPC-mediated tumor suppression can be mimicked in the adult brain by systemic administration of the synthetic vanilloid Arvanil, suggesting that TRPV1 agonists hold potential as new HG-astrocytoma therapeutics.
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480991/
_version_ 1611918853876482048